Home › Calculator › RAFA Dividend Calculator 2026
RAFA Dividend DRIP Calculator 2026
7407.41% YieldHealthcareRafarma Pharmaceuticals, Inc. · OTC
Price: $0.03 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RAFA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your RAFA snowball 📈
$10,000 in RAFA → $55539234390929.20M in 10 years · $4,566,620,160,411,873,000.00/month
About Rafarma Pharmaceuticals, Inc. (RAFA) — Dividend Analysis 2026
Rafarma Pharmaceuticals, Inc. is a diversified pharmaceutical enterprise that manufactures and distributes a range of medicinal products, including generic antibiotics and specialized drugs, within the Russian market. Its product portfolio encompasses anti-cancer medications, cephalosporin-derived compounds, and non-beta-lactam antibiotics. These are available in various formats such as injectable solutions, ampoules, pediatric suspensions, oral tablets, and capsules. Additionally, Rafarma develops and supplies treatments for injuries, ocular inflammatory conditions, and immunological ailments. In a collaborative effort with PlantEXT Ltd., the company is involved in the research and production of pioneering medical cannabis suppositories, specifically designed for individuals afflicted with inflammatory bowel disease. Originally incorporated as Johnston Acquisition Corp., the firm adopted its current name, Rafarma Pharmaceuticals, Inc., in October 2012. While headquartered in Sandy, Utah, its primary manufacturing and distribution operations are situated in Russia. Since October 19, 2020, Rafarma Pharmaceuticals, Inc. has functioned as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.
Compare RAFA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RAFA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RAFA position with:
🌍 RAFA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RAFA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 7407.41% | 7404.61% | $740,741 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 6296.30% | 6293.50% | $629,630 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 5925.93% | 5923.13% | $592,593 / yr |
| 🇬🇧 UK ISA | 0% | 7407.41% | 7404.61% | $740,741 / yr |
| 🇬🇧 UK Taxable | 8.75% | 6759.26% | 6756.46% | $675,926 / yr |
| 🇨🇦 TFSA | 0% | 7407.41% | 7404.61% | $740,741 / yr |
| 🇨🇦 CA Taxable | 25% | 5555.56% | 5552.76% | $555,556 / yr |
| 🇦🇺 Super (pension) | 15% | 6296.30% | 6293.50% | $629,630 / yr |
| 🇦🇺 AU Taxable | 30% | 5185.19% | 5182.39% | $518,519 / yr |
| 🇩🇪 DE Taxable | 26.375% | 5453.71% | 5450.91% | $545,371 / yr |
| 🇫🇷 FR Taxable | 30% | 5185.19% | 5182.39% | $518,519 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RAFA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RAFA Dividend Payment Schedule
RAFA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 RAFA vs Healthcare Benchmarks
How RAFA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RAFA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RAFA Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RAFA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Rafarma Pharmaceuticals, Inc. (RAFA) is currently trading at $0.03, 99% below its 52-week high. The current dividend yield is 7407.41% based on an annual payout of $2.00 per share.
RAFA (Rafarma Pharmaceuticals, Inc.) — 7407.41% Dividend Yield Analysis
Rafarma Pharmaceuticals, Inc. (RAFA) is a healthcare stock currently trading at $0.03 with a dividend yield of 7407.41%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, RAFA has grown its dividend at a compound annual rate of 50.0%.
- Above-average yield (7407.41%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.